HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 79 filers reported holding HUMACYTE INC in Q2 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $287,237 | +85.1% | 98,033 | +80.6% | 0.00% | – |
| Q2 2023 | $155,206 | +60.1% | 54,268 | +73.0% | 0.00% | – |
| Q1 2023 | $96,924 | +70.2% | 31,367 | +16.2% | 0.00% | – |
| Q4 2022 | $56,959 | -91.7% | 26,995 | -87.2% | 0.00% | – |
| Q3 2022 | $688,000 | -15.4% | 210,955 | -16.7% | 0.00% | – |
| Q2 2022 | $813,000 | -70.2% | 253,202 | -34.5% | 0.00% | – |
| Q1 2022 | $2,729,000 | -20.3% | 386,500 | -18.2% | 0.00% | – |
| Q4 2021 | $3,426,000 | -40.5% | 472,600 | -4.8% | 0.00% | -100.0% |
| Q3 2021 | $5,762,000 | – | 496,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| York Capital Management Global Advisors, LLC | 2,291,397 | $16,177,000 | 4.71% |
| Endowment Wealth Management, Inc. | 96,618 | $682,000 | 0.72% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 36,171 | $255,000 | 0.24% |
| Prescott General Partners LLC | 625,100 | $4,413,000 | 0.20% |
| CenterBook Partners LP | 45,752 | $323,000 | 0.12% |
| Gladstone Institutional Advisory LLC | 144,867 | $1,023 | 0.07% |
| Exos Asset Management LLC | 18,609 | $131,000 | 0.06% |
| Sciencast Management LP | 26,300 | $182,000 | 0.04% |
| Y-Intercept (Hong Kong) Ltd | 17,125 | $121,000 | 0.03% |
| Kovack Advisors, Inc. | 31,500 | $222,000 | 0.02% |